Isocitrate dehydrogenase 1 (IDH1) and IDH2 mutations are favorable prognostic factors and can facilitate diagnosing astrocytomas and oligodendrogliomas, whereas IDH-wildtype is associated with lower overall survival and characterizes glioblastomas [9]. This evidence concerns the gene IDH1 and glioblastoma.